查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1735633

2026 年至 2032 年大肠镜检查设备市场（按产品类型、最终用户、应用和地区）

Colonoscopy Devices Market By Product Type, By End- User, By Application, And Region for 2026-2032.
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

大肠镜检查设备市场评估（2026-2032）

随着全球大肠直肠癌发生率的上升和大肠镜检查数量的增加，大肠镜设备市场正在快速扩张。由于对创新、技术先进的器械和大肠镜设备的需求旺盛，预计市场规模还将扩大。根据 Verified Market Research 分析师预测，大肠镜设备市场规模将从 2024 年的约 15.9 亿美元下降到 2032 年预测期间的 22.5 亿美元。

大肠直肠癌发病率的上升和预防性筛检计画的日益普及正在推动大肠镜检查设备市场的发展，预计从 2026 年到 2032 年，大肠镜检查设备市场将以 5% 的复合年增长率成长。

人口老化如何推动大肠镜检查设备市场？

全球人口老化和慢性病盛行率上升推动了大肠镜检查设备市场的发展。根据世界卫生组织 (WHO) 的数据，到 2020 年，全球将有近 14 亿人年龄在 60 岁或以上。成年人罹患大肠癌的风险正在上升，这刺激了对大肠镜检查设备的需求。根据美国国家癌症中心的数据，全球每 10 万名男性和女性中，有 36.6% 患有大肠癌。每年每 10 万名男性和女性的死亡率为 13.1%。

美国国家医学图书馆预测，到2040年，大肠癌病例数将达到320万，导致大肠镜检查的频率更高。

此外，透过教育计画和公共卫生宣传活动，大肠直肠癌相关知识的提升，也有效地凸显了大肠直肠癌以及大肠镜检查作为预防性筛检手段的价值。随着公众意识的增强，越来越多的人选择接受大肠镜检查，从而推动了市场的成长。

感染风险将如何抑制大肠镜检查设备市场的成长？

儘管设备设计和消毒措施不断进步，但结肠镜检查过程中仍存在交叉污染和感染传播的风险。根据美国国家医学图书馆的数据，大肠直肠癌是第二大常见癌症。近期筛检中，已有超过30万人被诊断出罹患大肠癌。彻底清洗和消毒可重复使用的内视镜设备至关重要，但这也带来了物流和成本方面的挑战。一次性设备已被提案作为解决此问题的方案，但它会显着增加治疗成本，同时也引发了对医疗废弃物和环境的担忧。

此外，大肠镜检查的广泛普及也因设备和操作本身的高昂成本而受到阻碍。开发先进的大肠镜检查设备需要大量的研发、监管支出和复杂的製造流程。这些成本最终转嫁给医疗服务提供者，并最终转嫁给患者。在缺乏全面医疗保险体系或经济成长缓慢的国家，这些高昂的成本严重限制了人们获得这项可能挽救生命的检查的机会。

目录

第一章全球大肠镜检查设备市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球大肠镜设备市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球大肠镜设备市场（依产品类型）

  • 概述
  • 视觉化系统
  • 大肠镜检查
  • 其他设备

6. 全球大肠镜检查设备市场（依最终用户）

  • 概述
  • 医院
  • 诊所
  • 门诊手术中心
  • 诊断中心
  • 其他的

7. 全球大肠镜检查设备市场（按应用）

  • 概述
  • 大肠直肠癌
  • 林奇症候群
  • 溃疡性大肠炎
  • 克隆氏症
  • 息肉和结肠癌
  • 其他用途

8. 全球大肠镜检查设备市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第九章全球大肠镜设备市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • Boston Scientific
  • Fujifilm Holdings
  • HOYA Group
  • KARL STORZ
  • OLYMPUS
  • ANA-MED
  • Avantis Medical Systems
  • Endomed Systems
  • Getinge Group
  • HUGER Medical Instrument

第十一章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十二章 附录

  • 相关调查
简介目录
Product Code: 32334

Colonoscopy Devices Market Valuation-2026-2032

The market for colonoscopy devices is quickly rising as colorectal cancer rates rise and the number of colonoscopy procedures conducted worldwide increases. Also, the market is expected to grow because of the high demand for innovative, technologically sophisticated gadgets and colonoscopy equipment. According to the analyst from Verified Market Research, the Colonoscopy Devices Market is estimated to reach a valuation of USD 2.25 Billion over the forecast period 2032, subjugating around USD 1.59 Billion valued in 2024.

The rising frequency of colorectal cancer, as well as the expanding acceptance of preventative screening programs, are driving the Colonoscopy Devices Market. It enables the market to grow at a CAGR of 5% from 2026-2032.

How is the Geriatric Population Driving the Colonoscopy Devices Market?

The increasing aging population globally, and the increasing prevalence of chronic disorders over the globe are driving the Colonoscopy Devices Market. According to the World Health Organization (WHO) in 2020 almost 1.4 billion people were above 60 years aged. The risk of colorectal cancer is increasing in adults, which is fueling the demand for colonoscopy devices. According to the National Cancer Institute, globally 36.6% of people per 100,000 men and women were detected by colorectal cancer. The death rate was 13.1% per 100,000 men and women per year.

The increasing number of colorectal cancer is predicted by the National Library of Medicine by 2040 will be 3.2 million and the disease is leading to more frequent colonoscopy procedures.

Furthermore, increasing knowledge about colorectal cancer educational programs and public health campaigns are doing a good job of bringing colorectal cancer and the value of colonoscopies as a preventive screening to light. As a result of this greater awareness, more people are choosing to have colonoscopies, which propels market expansion.

How Does Risk of Infection Constrain the Growth of the Colonoscopy Devices Market?

Despite advances in gadget design and sterilizing measures, there is still a danger of cross-contamination and infection transmission during colonoscopy procedures. According to the National Library of Medicine, colorectal cancer is the second cancer. Recent examinations show that more than 300,000 people were detected with colorectal cancer. The thorough cleaning and sanitation of reusable endoscopic equipment is vital, but it poses logistical and cost issues. Single-use devices have been offered as a solution to this problem, however, they significantly enhance the cost of treatments while also raising concerns about medical waste and the environment.

Furthermore, the high expense of both the gadgets and the procedures themselves is a significant impediment to the widespread use of colonoscopy. The development of sophisticated colonoscopy gadgets necessitates extensive R&D, regulatory compliance expenditures, and manufacturing complexity. These costs are passed on to healthcare providers and, eventually, patients. In nations with less comprehensive health insurance coverage or lesser economic growth, these expenses severely limit access to potentially life-saving surgeries.

Category-Wise Acumens

Will Visualization Systems Outplace Colonoscopy Device Market?

The visualization system is estimated to exhibit the highest growth within the market during the forecast period. The visualization system is used to screen for cancer in the small intestine, rectum, and anus. A minimally intrusive diagnostic for assessing the possibility of internal organ cancer is a virtual colonoscopy.

Screening (CT) colonography is another name for virtual colonoscopy. It is used for radiologist X-rays. It finds the diseases at an early stage. According to the National Institute of Diabetes and Digestive and Kidney Diseases, doctors recommend CT screening for colonoscopy and rectal cancer at the age of 45 if there is no health issue.

Furthermore, colonoscopy usage is expected to increase as long as technology continues to evolve, leading to better mobility and disposable choices. Visualization systems currently don't outplace colonoscopy devices.

How the increasing prevalence of Colorectal Cancer in adults is driving the Colorectal Cancer segment?

The colorectal cancer segment is estimated to dominate the market during the forecast period. In the U.S. around 18,000 people under the age of 50 are getting diagnosed with colorectal cancer. According to the National Cancer Institute, the risk of colorectal cancer is increasing in older adults because of smoking, physical inactivity, and obesity.

Risk fare increasing in adults under the age of 45, 10% to 20% of early-onset colorectal cancer is caused because of inherited factors. Due to an unhealthy diet, and low intake of fruits and vegetables the early stage the cancer is caused.

Furthermore, the growth incidence and its impact on the demand for colonoscopy devices can be attributed to several factors such as lifestyle, rising healthcare expenditure, increasing awareness, and screening efforts. The combination of demographic trends and infrastructure improvements contributes to the growing incidence of colorectal cancer and, consequently, the increasing demand for colonoscopy devices.

Country/Region-wise Acumens

How does the Developed Healthcare System Drive the North American Colonoscopy Devices Market?

North America region is estimated to dominate the market during the forecast period due to the improving prevalence of rectal diseases, the existence of a developed healthcare system, the growing emphasis on the development of innovative products, and the increasing number of companies manufacturing colonoscopy devices. The governments are running several health campaigns to raise awareness of colon problems among the local populace.

North America, particularly the United States, has one of the most advanced healthcare systems in the world. This comprises cutting-edge medical facilities, advanced medical technologies, and highly skilled healthcare staff. Also, healthcare spending in the region is far higher than in other parts of the world. This financial commitment promotes the use of modern medical technology, particularly colonoscopy machines, which aid in the early identification and treatment of gastrointestinal disorders such as colorectal cancer.

Furthermore, Colorectal cancer is common in North America and is the biggest cause of cancer-related fatalities in the region. The American Cancer Society emphasizes the significance of regular screening for early identification of colorectal cancer, which drives up demand for colonoscopy instruments. Also, the increasing prevalence of other gastrointestinal disorders as a result of food habits, lifestyle changes, and an older population drives up demand for these devices.

What Factors Contribute to the Growth of the Asia Pacific Region in the Market?

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. Countries in the Asia Pacific region, including China, India, and Japan, are experiencing significant increases in healthcare spending, both at the government and individual levels. This increased spending is being directed toward modernizing healthcare infrastructure, such as hospitals and diagnostic facilities outfitted with cutting-edge medical technology. As healthcare accessibility grows, so does the adoption of advanced diagnostic instruments, such as colonoscopy devices, to meet an increasing demand for high-quality healthcare services.

Furthermore, the Asia Pacific region is experiencing a rapid increase in the prevalence of colorectal cancer and other gastrointestinal disorders, which can be ascribed to changing lifestyles, dietary habits, and aging populations. These factors have raised awareness about the need for early detection and prevention, increasing demand for colonoscopy treatments. Countries such as Japan have adopted screening programs that encourage regular colonoscopies, setting an example for other nations in the region.

Competitive Landscape

The competitive landscape of the colonoscopy device market is characterized by several key players and factors that influence market dynamics, innovation, and strategic initiatives. These players compete based on product offerings, technological advancements, market presence, pricing strategies, distribution networks, and partnerships.

Some of the prominent players operating in the Colonoscopy Devices Market include:

Boston Scientific, PENTAX Medical, Fujifilm Holdings, HOYA Group, Avantis Medical System, KARL STORZ, Medtronic, OLYMPUS, ANA-MED, Endomed Systems, Getinge Group, GI-View, HUGER Medical Instrument

Latest Developments

In March 2022, the FDA approved Wision A.I.'s colonoscopy technology for polyp detection. This approval will enhance patient outcomes and contribute to a decrease in colorectal cancer incidences.

In April 2022, Olympus 510(k) cleared the PCF colonoscope series, and SMART Medical Systems Ltd., a producer of cutting-edge endoscopic equipment, announced an additional Food and Drug Administration clearance for their G-EYE Colonoscope.

Colonoscopy Devices Market By Category

Product Type:

Visualization system

Colonoscope

Other instruments

End-use:

Hospitals

Clinics

Ambulatory Surgery Centers

Diagnostic Centers

Other

Application:

Colorectal Cancer

Lynch Syndrome

Ulcerative Colitis

Crohn's Disease

Polyps or Colorectal Cancer

Other Applications

Region:

North America

Europe

Asia-Pacific

South America

Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL COLONOSCOPY DEVICES MARKET

  • 1.1. Overview of the Market
  • 1.2. Scope of Report
  • 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1. Data Mining
  • 3.2. Validation
  • 3.3. Primary Interviews
  • 3.4. List of Data Sources

4. GLOBAL COLONOSCOPY DEVICES MARKET OUTLOOK

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Porters Five Force Model
  • 4.4. Value Chain Analysis

5. GLOBAL COLONOSCOPY DEVICES MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Visualization system
  • 5.3 Colonoscope
  • 5.4 Other instruments

6. GLOBAL COLONOSCOPY DEVICES MARKET, BY END-USE

  • 6.1. Overview
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Ambulatory Surgery Centers
  • 6.5 Diagnostic Centers
  • 6.6 Other

7. GLOBAL COLONOSCOPY DEVICES MARKET, BY APPLICATION

  • 7.1. Overview
  • 7.2 Colorectal Cancer
  • 7.3 Lynch Syndrome
  • 7.4 Ulcerative Colitis
  • 7.5 Crohn's Disease
  • 7.6 Polyps or Colorectal Cancer
  • 7.7 Other Applications

8. GLOBAL COLONOSCOPY DEVICES MARKET, BY GEOGRAPHY

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Rest of Europe
  • 8.4. Asia Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia Pacific
  • 8.5. Rest of the World
    • 8.5.1. Latin America
    • 8.5.2. Middle East & Africa

9. GLOBAL COLONOSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1. Overview
  • 9.2. Company Market Ranking
  • 9.3. Key Development Strategies

10. COMPANY PROFILES

  • 10.1. Boston Scientific
    • 10.1.1. Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Outlook
    • 10.1.4. Key Developments
  • 10.2. Fujifilm Holdings
    • 10.2.1. Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Outlook
    • 10.2.4. Key Developments
  • 10.3. HOYA Group
    • 10.3.1. Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Outlook
    • 10.3.4. Key Developments
  • 10.4. KARL STORZ
    • 10.4.1. Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Outlook
    • 10.4.4. Key Developments
  • 10.5. OLYMPUS
    • 10.5.1. Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Outlook
    • 10.5.4. Key Developments
  • 10.6. ANA-MED
    • 10.6.1. Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Outlook
    • 10.6.4. Key Developments
  • 10.7. Avantis Medical Systems
    • 10.7.1. Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Outlook
    • 10.7.4. Key Developments
  • 10.8. Endomed Systems
    • 10.8.1. Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Outlook
    • 10.8.4. Key Developments
  • 10.9. Getinge Group
    • 10.9.1. Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Outlook
    • 10.9.4. Key Developments
  • 10.10. HUGER Medical Instrument
    • 10.10.1. Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Outlook
    • 10.10.4. Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12. Appendix

  • 12.1. Related Research